tiprankstipranks
Advertisement
Advertisement
Ensysce Biosciences secures second financing from 2025 agreement
PremiumThe FlyEnsysce Biosciences secures second financing from 2025 agreement
3M ago
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
Premium
Company Announcements
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
3M ago
ENSC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ENSC Earnings this Week: How Will it Perform?
3M ago
Ensysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
PremiumThe FlyEnsysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
5M ago
Ensysce Biosciences expands global opioid patent portfolio
Premium
The Fly
Ensysce Biosciences expands global opioid patent portfolio
5M ago
Ensysce Biosciences Shareholders Approve Key Corporate Actions
Premium
Company Announcements
Ensysce Biosciences Shareholders Approve Key Corporate Actions
6M ago
Ensysce Biosciences files to sell 4.6M shares of common stock for holders
PremiumThe FlyEnsysce Biosciences files to sell 4.6M shares of common stock for holders
7M ago
Ensysce Biosciences issued notice of allowance for MPAR tech patent
Premium
The Fly
Ensysce Biosciences issued notice of allowance for MPAR tech patent
7M ago
Ensysce Biosciences receives FDA feedback on PF614 manufacturing
Premium
The Fly
Ensysce Biosciences receives FDA feedback on PF614 manufacturing
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100